The Norwegian Sonothrombolysis in Acute Stroke Study Part 2 (NOR-SASS 2)
Randomised Trial of Contrast-enhanced Sonothrombolysis in Acute Ischaemic Stroke
Sponsor: Haukeland University Hospital
Terminated
Lack of funding for researchers
Other terminated trials from Haukeland University Hospital
Other Ischemic Stroke trials with similar outcome
This NA trial investigates Ischemic Stroke and is currently terminated or withdrawn. Haukeland University Hospital leads this study, which shows 9 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
May 2020 — Jan 2021 [monthly]
Terminated NA
Status: Recruiting → Terminated · Phase: PHASE3 → NA
-
Nov 2019 — May 2020 [monthly]
Recruiting PHASE3
▶ Show 4 earlier versions
-
Sep 2018 — Nov 2019 [monthly]
Recruiting PHASE3
-
Jun 2018 — Sep 2018 [monthly]
Recruiting PHASE3
-
Mar 2017 — Jun 2018 [monthly]
Recruiting PHASE3
Status: Terminated → Recruiting · Phase: PHASE2_PHASE3 → PHASE3
-
Jan 2017 — Mar 2017 [monthly]
Terminated PHASE2_PHASE3
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Haukeland University Hospital
- Sykehuset Telemark
- University of Bergen
For direct contact, visit the study record on ClinicalTrials.gov .